NEW YORK, April 10, 2018 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against LJM Funds Management Ltd. (“LJMIX” or the “Company”) (LJMIX) and certain of its officers, on behalf of shareholders who purchased LJM Preservation and Growth Fund Class I (“LJMIX”) (MUTF:LJMIX) between February 28, 2015 and February 7, 2018, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/ljmix.
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, defendants made materially false and misleading statements and/or failed to disclose that: (1) LJMIX was not focused on capital preservation and left investors exposed to an unacceptably high risk of catastrophic losses; and (2) LJMIX had not taken appropriate steps to preserve capital in down markets.
On February 5, 2018, the S&P dropped about 4.6% and LJMIX dropped roughly 80% from a previous close price of $9.82 per share on February 2, 2018 to $1.94 per share on February 7, 2018.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/ljmix or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in LJMIX you have until April 10, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]


AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 



